InvestorsObserver
×
News Home

Is Vascular Biogenics Ltd (VBLT) a Winner in the Biotechnology Industry?

Tuesday, October 03, 2023 01:58 PM | InvestorsObserver Analysts

Mentioned in this article

Is Vascular Biogenics Ltd (VBLT) a Winner in the Biotechnology Industry?

Vascular Biogenics Ltd (VBLT) is near the middle in its industry group according to InvestorsObserver. VBLT gets an overall rating of 47. That means it scores higher than 47 percent of stocks. Vascular Biogenics Ltd gets a 61 rank in the Biotechnology industry. Biotechnology is number 78 out of 148 industries.

Overall Score - 47
VBLT has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on VBLT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 47 means the stock is more attractive than 47 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Vascular Biogenics Ltd Stock Today?

Vascular Biogenics Ltd (VBLT) stock has gained 4.51% while the S&P 500 is down -1.51% as of 1:49 PM on Tuesday, Oct 3. VBLT has gained $0.01 from the previous closing price of $0.24 on volume of 506,833 shares. Over the past year the S&P 500 is higher by 14.82% while VBLT has gained 62.50%. VBLT lost -$0.21 per share the over the last 12 months. Click Here to get the full Stock Report for Vascular Biogenics Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App